Evotec and Odyssey partner on autoimmune drug discovery
Go back to Evotec and Odyssey partner on autoimmune drug discovery| EATON VANCE OHIO MUNI INCOME T (NASDAQ: EVO) | Delayed: 1.81 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.81 | 52 Week High | $16.39 | |||
| Open | $1.81 | 52 Week Low | $13.22 | |||
| Day High | $1.81 | P/E | N/A | |||
| Day Low | $1.81 | EPS | $-1.61 | |||
| Volume | 32 | |||||
| EATON VANCE TAX-ADVANTAGED DIVIDEND INCOME FUND (NYSE: EVT) | Delayed: 28.74 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.74 | 52 Week High | $21.25 | |||
| Open | $28.74 | 52 Week Low | $16.37 | |||
| Day High | $28.74 | P/E | N/A | |||
| Day Low | $28.74 | EPS | $0.00 | |||
| Volume | 1 | |||||
| (NASDAQ: ODTX) | Delayed: 24.51 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.51 | 52 Week High | $ | |||
| Open | $24.51 | 52 Week Low | $ | |||
| Day High | $24.51 | P/E | N/A | |||
| Day Low | $24.51 | EPS | $ | |||
| Volume | 7 | |||||

